Cambridge, MA · Founded 2022 · Privately Held (backing)
Operator of a biotechnology company intended to cure neurological disease. Kenai Therapeutics is based in Cambridge, MA and was founded in 2022. Its last known valuation is $110 million. It has raised $86.8 million.
Last price · $/share
—
Implied valuation
$110.0M
Total raised
$86.8M
Last round
—
Cap table — not yet on record
Kenai Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kenai Therapeutics with a free account
·Watch Kenai Therapeutics: the Monday email on marks, rounds and moves
